Latest glioblastoma multiforme Stories
In-demand research report “Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM”
NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of
First Patient Has Begun Treatment Process; Additional Patients Being Assessed; Waiting List Established BETHESDA, Md., Oct.
SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- DNAtrix, a clinical-stage oncolytic immunotherapy company, announced that it has completed a $20M Series B equity financing.
TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized
- $5.8 million award will help advance the development of oxygen-carrying therapeutics for cancer - SAN CARLOS, Calif., Oct.
DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.
SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc.
VANCOUVER, British Columbia and MENLO PARK, Calif., Oct.
SAN ANTONIO, Sept. 30, 2014 /PRNewswire/ -- GenSpera, Inc.
- A transitional zone between two communities containing the characteristic species of each.